Drug test is referred as analysis of biological samples such as urine, blood plasma, breath, and sweat. Specimen validity test (SVT) is defined as analysis of specimen to evaluate consistency with normal human urine. It is performed on specimen to detect dilution, substitution, or adulteration. The Substance Abuse and Mental Health Services Administration (SAMHSA) has provided guidelines that laboratories must follow while performing specimen validity testing. According to the SAMHSA guidelines, specimen validity testing consists of measurement of physical characteristics, creatinine level, specific gravity, pH, oxidizing adulterants, and interfering substances. SVT is an integral part of every urine drug screening and used routinely in several applications such as drug screening, pain management studies, and abuse testing.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52056
Usage of illicit drugs is rising across the world. According to data published by the National Institute of Drug Abuse, illicit drug usage in the U.S. has been increasing. In 2013, an estimated 24.6 million people in the country aged 12 or older (9.4% of the population) had used an illicit drug. Rise in usage of illicit drugs is a key driver of the global specimen validity testing market. Moreover, strict laws mandating drug screening and government funding to control drug abuse are projected to fuel the growth of the global market during the forecast period. However, lack of awareness and emergence of alternative techniques are anticipated to hamper the growth of the global specimen validity testing market during the forecast period.
Request COVID Analysis on Specimen Validity Testing Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=52056
The global specimen validity testing market can be segmented based on product, type of testing, end-user, and region. In terms of product, the global market can be classified into reagents, assay kits, disposables, and others. Based on type of testing, the global specimen validity testing market can be categorized into in-office or laboratory testing and rapid or point-of-care testing. In terms of end-uses, the global market can be divided into criminal justice & law enforcement agencies, drug screening laboratories, drug rehabilitation centers, pain management centers, and others.
Request Customization on Specimen Validity Testing Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=52056
Geographically, the global specimen validity testing market can be segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America and Europe are expected to dominate the market due to high awareness and adoption of testing in these regions. Asia Pacific is considered to be a lucrative market that is anticipated to expand at the highest growth rate during the forecast period. Growth of the specimen validity testing market in Asia Pacific is attributed to strong economic growth, increase in disposable income, rise in health care infrastructure, and surge in funding from market players to curb drug abuse in this region. Brazil is the fastest growing market for specimen validity testing in Latin America. The market in the Middle East is considered to be in a development phase.
Pre Book Specimen Validity Testing Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=52056<ype=S
The global specimen validity testing market is highly organized, with few players accounting for major share in terms of revenue. Key players in the global market include Thermo Fisher Scientific, Sciteck, Inc., Alere (now part of Abbott), Premier Biotech, Inc., American Bio Medica Corporation, and Express Diagnostics, Inc.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com
It is consequently, an acknowledged method of testing for example legitimacy when observing for mishandled drugs whether inside the working environment, criminal equity framework (for example drug courts) or for compliance.1 as a rule, human pee reflects drugs devoured inside the previous a few days relying upon drug use.
What's Trending in Market:Regulatory Approvals for Rapid Testing ProductsRestraints:Alternative Drug Screening TestsMarket Growth Drivers:Growth in the Drug Screening and strict laws mandating drug screening and government funding to control drug abuse are projected to fuel the growthIncrease in Workplace Drug TestingGlobal Specimen Validity Testing Market Development Scenario by Players Ø Financials Information, Business Overview and Product Specification Matrix Ø Patent Analysis Briefing* [if applicable] Ø No.
of Patents Issuance by Year / by Players / By Issuing Office Ø Key Development – Product/Service Launch, Mergers & Acquisition, Joint Ventures Specimen Validity Testing Market Competition Each company profiled in the research document is studied considering various factors such as product and its application portfolios, market share, growth potential, future plans, and development activity.
Yes, we can add or profile new company as per client need in the report, provided it is available in our coverage list as mentioned in answer to Question 1 and after feasibility run final confirmation will be provided by research team checking the constraints related to difficulty of survey.
2) Can we narrow the available business segments?
What all regional slits covered with covid impact analysis?
Growing global incidence of substance abuse, increasing cases of prescription diversion, and stringent laws mandating drug screening tests are key factors driving market growth Market Size – USD 1.25 Billion in 2020, Market Growth – at a CAGR of 6.6%, Market Trends – Increasing adoption of urine drug testing at workplaces The global specimen validity testing market size is expected to reach USD 2.10 Billion by 2028 at a CAGR of 6.6%, according to the latest report by Reports and Data.
Clinicians generally order SVT to make informed therapeutic decisions about medical conditions of their patients, which also includes therapeutic overuse and illicit drug abuse.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4098Some Key Highlights From the Report:Reagents, calibrators, and controls segment is expected to account for largest revenue share among the products segment.
Growth can be attributed to increasing demand and repeated purchase of reagents due to rising number of specimens being tested in drug screening laboratories.Laboratory testing segment is expected to register robust revenue CAGR over the forecast period owing to increasing drug testing in established healthcare facilities, rising cases of drug abuse, and implementation of standardized specimen validity testing protocols in laboratories.Workplace segment is expected to register significant revenue growth over the forecast period owing to rising incidence of drug abuse at workplaces and increasing number of offices and organizations mandating workplace drug screening.North America is expected to account for largest revenue share between 2021 and 2028, attributable to growing use of illicit drugs, increasing incidence of prescription diversion, and presence of stringent laws mandating drug screening in countries in the region.
The key companies profiled in the market are: Thermo Fisher Scientific, Inc., Sciteck, American Bio Medica Corporation, Alere, Express Diagnostics, Premier Biotech, LabCorp., Quest Diagnostics, Alere Toxicology, ACM Global Laboratories, Clinical Reference Laboratory (CRL), SureHire, and CannAmm.For the purpose of this report, Reports and Data has segmented the global specimen validity testing market based on product & services, type, end-use, and region: Product & Services Outlook (Revenue, USD Billion; 2018-2028)ProductsReagents, Calibrators, & ControlsAssay KitsDisposableServicesType Outlook (Revenue, USD Billion; 2018-2028)Laboratory TestingRapid/POC TestingEnd-use Outlook (Revenue, USD Billion; 2018-2028) WorkplacesDrug Screening LaboratoriesLaw Enforcement AgenciesPain Management CentresDrug Rehabilitation CentresOthers Browse Complete Report “Specimen Validity Testing Market” @ https://www.reportsanddata.com/report-detail/specimen-validity-testing-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
In-depth regional analysis covers: North AmericaU.S.CanadaMexicoEuropeGermanyU.K.FranceBENELUXRest of EuropeAsia PacificChinaJapanSouth KoreaRest of APACLatin AmericaBrazilRest of LATAMMiddle East & AfricaSaudi ArabiaA.E.Rest of MEAThe report includes primary and subjective research with a comprehensive study examined and validated by industry professionals and experts.
